Dr Andrew Gaya
Consultant Clinical Oncologist
MD MRCP FRCR
Languages spoken: English
Dr Andrew Gaya
Consultant Clinical Oncologist
MD MRCP FRCR
Languages spoken: English
Appointments available at:
Cromwell HospitalPatient Age Group
AdultsYear qualified
1995Gender
MaleSpecialty
Clinical oncologySubspecialty
GastrointestinalClinical Interests
Gastrointestinal cancers (oesophagus, stomach, liver, pancreas, colon, rectum, anal); stereotactic radiotherapy and radiosurgery (Gamma Knife Icon, CyberKnife, MRIdian MR Linac); chemotherapy, biological therapy, and immunotherapy; molecular and genetic profiling of cancers.
About Dr Andrew Gaya
Dr Andrew (Andy) Gaya is a consultant clinical oncologist, specialising in the treatment of gastrointestinal cancers. He is a member of GenesisCare, who run the radiotherapy centre at Cromwell Hospital.
Dr Gaya treats all gastrointestinal tumours (oesophagus, stomach, liver, pancreas, colon, rectum, and anus) using chemotherapy, radiotherapy, immunotherapy, biological therapies, and data from tumour genome analysis. His main interests are in the areas of functional cancer imaging.
Dr Gaya qualified at St George’s Hospital Medical School (University of London), where he was awarded a distinction and several academic prizes. He trained in clinical oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London.
He was heavily involved with the implementation of the latest radiotherapy techniques in the UK, including stereotactic ablative radiotherapy (SABR) and proton therapy. He was also one of the first UK oncologists to use the CyberKnife.
Dr Gaya treats all gastrointestinal tumours (oesophagus, stomach, liver, pancreas, colon, rectum, and anus) using chemotherapy, radiotherapy, immunotherapy, biological therapies, and data from tumour genome analysis. His main interests are in the areas of functional cancer imaging.
Dr Gaya qualified at St George’s Hospital Medical School (University of London), where he was awarded a distinction and several academic prizes. He trained in clinical oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London.
He was heavily involved with the implementation of the latest radiotherapy techniques in the UK, including stereotactic ablative radiotherapy (SABR) and proton therapy. He was also one of the first UK oncologists to use the CyberKnife.
NHS Base (trust)
Private only
Professional memberships
American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO), European Society for Radiotherapy and Oncology (ESTRO), Independant Doctors Federation, Medical Protection Society (MPS), Royal College of Physicians, Royal College of Radiologists (RCR)
